Canada Adds Actos Bladder Cancer Risk Warning
In Canada, health officials have issued new warnings about the risk of Actos bladder cancer associated with the drug used to treat Type II Diabetes.
Health Canada issued the new Actos warnings last week based on results from a safety review conducted over the summer. The FDA issued similar Actos warnings for users in the U.S.
According to Health Canada, the risk of developing bladder cancer increases the longer a person takes Actos. The new warnings will be added to all Actos labels in Canada. In addition to this labeling change, Health Canada is also urging doctors to carefully evaluate the risks of Actos versus the benefits for patients who already have bladder problems or blood in their urine.
Developed by Takeda Pharmaceuticals, Actos (pioglitazone) was approved by the FDA in 1999 for the treatment of Type II Diabetes. Actos is given once daily and works to increase the body’s sensitivity to insulin. Following safety concerns over Avandia, another diabetes drug, Actos has grown in popularity, generating $4.3 billion in sales in 2011.
In September 2010, interim data from an ongoing 10-year study conducted by Takeda showed an increased risk for bladder cancer among Actos users, and this data prompted an FDA review of the drug.
In France and Germany, an Actos recall has been issued, while health officials have increased label warnings for Actos sold in the U.S. and in the rest of Europe.
As a result of an unacceptably high incidence of Actos bladder cancer, a number of Actos lawsuits have been filed against Takeda Pharmaceuticals by patients who claim that the drug maker was negligent in failing to provide adequate warnings for Actos and that they concealed the risk from doctors and patients.
All federal Actos lawsuits have been consolidated into a multidistrict litigation (MDL) for pretrial proceedings, centralized in the U.S. District Court for the Western District of Louisiana. A Canadian class action lawsuit was filed on behalf of all Canadians diagnosed with bladder cancer while taking Actos. The claim was initiated by the state of a woman from Toronto who died of Actos-induced bladder cancer in 2011.
Contact an Actos Lawyer
If you have been diagnosed with bladder cancer after taking Actos, the diabetes drug may be responsible for your illness. A qualified personal injury lawyer can help you further investigate this matter and pursue just compensation for your damages. Contact a pharmaceutical product liability lawyer today to learn more in a free legal consultation.